The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTUNG.L Regulatory News (TUNG)

  • There is currently no data for TUNG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

18 Feb 2016 14:24

RNS Number : 5012P
Tungsten Corporation PLC
18 February 2016
 

TUNGSTEN CORPORATION PLC

("Tungsten" or the "Company")

 

18 February 2016

Directors' Shareholdings

Further to yesterday's announcement concerning the purchase of 50,000 ordinary shares ("Shares") by Nicholas Parker, Chairman, Tungsten confirms that it was informed on 18 February of further purchases by Mr Parker and on 27 January of purchases by David Williams, CFO, as follows:

Director

Dealing Date

Purchase Price

Number of Shares

Nature of Holding

David Williams

26 Jan 2016

62.3 pence

1,605

For son

David Williams

27 Jan 2016

63.03 pence

793

For son

David Williams

27 Jan 2016

62.28 pence

802

For son

Nicholas Parker

17 Feb 2016

64.0 pence

25,000

 

Nicholas Parker

18 Feb 2016

68.0 pence

25,000

 

Accordingly, Mr Parker now has a total beneficial interest in 350,000 ordinary shares, representing 0.3% of the total voting rights of the Company. Mr Williams has a total beneficial interest in 3,200 ordinary shares, representing 0.003% of the total voting rights of the Company and options over 100,000 ordinary shares exercise price of 67.5p, representing 0.086% of the Company's issued share capital.

Enquiries:

 

 

Tungsten Corporation plc

Cynthia Alers, Head of Investor Relations

+44 20 7280 7872

 

Panmure Gordon (Nominated Advisor)

Fred Walsh/Dugald J. Carlean

+44 20 7886 2500

 

Canaccord Genuity Limited (Broker)

Simon Bridges/Emma Gabriel/Cameron Duncan

 

+44 20 7523 8000

Neustria Partners

Robert Bailhache/Nick Henderson/Charles Gorman

+44 20 3021 2580

 

About Tungsten Corporation plcTungsten Corporation (LSE: TUNG) accelerates global trade by enabling customers to streamline invoice processing, improve cash-flow management and make better buying decisions from their detailed spend data.

 Buyer organisations that join Tungsten Network, the world's largest compliant electronic invoicing network, can reduce their invoice-processing costs by 60%. Suppliers benefit from efficiencies, greater visibility of their invoice status and peace of mind. Tungsten offers options for supply chain financing and helps buying organisations profit by applying real-time spend analytics to its vast repository of line-level invoice data.

Tungsten serves 56% of the Fortune 500 and 67% of the FTSE 100 by connecting the world's largest companies and government agencies to their thousands of suppliers around the globe. It enables suppliers to submit tax compliant e-Invoices in 47 countries, and last year processed transactions worth over $187bn for organisations such as Alliance Data, Aviva, Cargill, Deutsche Lufthansa, General Motors, GlaxoSmithKline, Henkel, IBM, Kellogg's, and the US Federal Government.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSFEFLAFMSEEE
Date   Source Headline
20th Jun 20227:00 amRNSCancellation - Tungsten Corporation Plc
17th Jun 20222:30 pmRNSForm 8.3 - Tungsten Corp PLC
17th Jun 202211:00 amRNSLapse of Offer
17th Jun 202210:19 amBUSForm 8.3 - Tungsten Corporation plc
17th Jun 202210:15 amRNSScheme Becomes Effective
17th Jun 20227:30 amRNSSuspension - Tungsten Corporation plc
16th Jun 20224:50 pmRNSHolding(s) in Company
16th Jun 202211:35 amRNSForm 8.3 - TUNGSTEN CORP PLC
16th Jun 202211:32 amRNSForm 8.3 - TUNGSTEN CORP PLC
16th Jun 20227:59 amGNWForm 8.5 (EPT/RI) - Tungsten Corporation Plc
15th Jun 20226:13 pmRNSReplace - Exercise Options, Issue Equity, Rule 2.9
15th Jun 20221:31 pmRNSEXERCISE OF OPTIONS, ISSUE OF EQUITY AND RULE 2.9
15th Jun 20221:27 pmRNSCOURT SANCTION OF SCHEME OF ARRANGEMENT
15th Jun 202211:06 amBUSForm 8.3 - Tungsten Corporation plc
14th Jun 20221:00 pmRNSHolding(s) in Company
14th Jun 20228:03 amGNWForm 8.5 (EPT/RI) - Tungsten Corporation Plc
13th Jun 20225:30 pmRNSTungsten Corporation
10th Jun 20227:00 amRNSAnnouncement of Acceptance Levels
9th Jun 20224:00 pmRNSResults of Reconvened Court Meeting and GM
7th Jun 20228:43 amGNWForm 8.5 (EPT/RI) Tungsten Corporation Plc
6th Jun 20227:00 amRNSResponse to Announcement by Pagero Group AB
6th Jun 20227:00 amRNSForm 8.3 - Tungsten Corp PLC
1st Jun 20225:15 pmRNSNo increase statement
1st Jun 20223:06 pmRNSForm 8.3 - Tungsten Corp PLC
1st Jun 20221:09 pmPRNForm 8.3 - Tungsten Corporation Plc
1st Jun 20229:12 amRNSForm 8.5 (EPT/RI)
31st May 20224:00 pmRNSLapse of Irrevocable Undertaking
31st May 20221:47 pmRNSHolding(s) in Company
31st May 202212:56 pmPRNForm 8.3 - Tungsten Corporation Plc
30th May 202212:43 pmPRNForm 8.3 - Tungsten Corporation Plc
30th May 20227:00 amRNSUpdate on Offer
27th May 202212:20 pmPRNForm 8.3 - Tungsten Corporation Plc
27th May 202210:00 amRNSUpdate on Financing Arrangements
26th May 20224:00 pmRNSPublication and Posting of Shareholder Circular
26th May 202212:34 pmPRNForm 8.3 - Tungsten Corporation Plc
25th May 202212:27 pmPRNForm 8.3 - Tungsten Corporation Plc
24th May 202212:11 pmPRNForm 8.3 - Tungsten Corporation Plc
23rd May 20225:54 pmRNSForm 8.3 - Tungsten Corporation PLC
23rd May 20225:51 pmRNSForm 8.3 - Tungsten Corporation PLC
23rd May 20225:49 pmRNSForm 8.3 - Tungsten Corporation PLC
23rd May 20225:46 pmRNSForm 8.3 - Tungsten Corporation PLC
23rd May 20225:39 pmRNSForm 8.3 - Tungsten Corporation PLC
23rd May 20225:26 pmRNSHolding(s) in Company
23rd May 20225:23 pmRNSHolding(s) in Company
23rd May 20224:26 pmRNSHolding(s) in Company
23rd May 20224:25 pmRNSHolding(s) in Company
23rd May 20224:00 pmRNSLapse of Irrevocable Undertakings
23rd May 20223:07 pmRNSForm 8.3 - TUNGSTEN CORP PLC
23rd May 20222:33 pmRNSForm 8.3 - Tungsten Corp PLC
23rd May 202212:26 pmPRNForm 8.3 - Tungsten Corporation Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.